Literature DB >> 30852480

Adverse reactions of fluoroquinolones to central nervous system and rational drug use in nursing care.

Li Haiping1, Jiang Ziqiang2, Zhao Qina1, Ding Yuhua3.   

Abstract

.Fluoroquinolones are a kind of synthetic drugs commonly used in clinical treatment. They have good broad-spectrum antimicrobial properties. They are not only convenient to administer, but also have remarkable therapeutic effects. In this paper, we selected 70 patients with adverse reactions of central nervous system during the use of fluoroquinolones as the research object. We reviewed and analyzed the basic data, main manifestations and outcomes of adverse reactions, and summarized the influencing factors. The results showed that dizziness, irritability and insomnia were the main symptoms in 42 patients with mild adverse reactions. In 28 patients with moderate to severe adverse reactions, neuropsychiatric symptoms such as restlessness, depression, nervous excitation, phonism and hallucination were found. 54 patients were able to recover after stopping the medication. The remaining 16 patients were treated with drugs, and the effective rate was 87.5%. By analyzing the related factors, it can be seen that elderly patients over 60 years old, intravenous administration, combination of drugs and past history of neurological diseases are the main factors leading to adverse reactions of the central nervous system. In this survey, there were 7 kinds of adverse drug reactions, of which 31 cases (44.28%) were caused by levofloxacin. Therefore, fluoroquinolones have adverse effects on the central nervous system in the course of treatment, and the occurrence of adverse reactions is related to patients' age, route of administration, drug combination and past history of illness. It is important to grasp the above factors and make rational use of drugs.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30852480

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  4 in total

1.  Utilization of potentially inappropriate medication and risk of adverse drug events among older adults with chronic renal insufficiency: a population-wide cohort study.

Authors:  Safoura Sheikh Rezaei; Hana Šinkovec; Alexander Schöberl; Christoph Rinner; Georg Heinze; Michael Wolzt; Walter Gall
Journal:  BMC Geriatr       Date:  2021-02-10       Impact factor: 3.921

2.  GPCR_LigandClassify.py; a rigorous machine learning classifier for GPCR targeting compounds.

Authors:  Marawan Ahmed; Horia Jalily Hasani; Subha Kalyaanamoorthy; Khaled Barakat
Journal:  Sci Rep       Date:  2021-05-04       Impact factor: 4.379

3.  A VigiBase Descriptive Study of Fluoroquinolone-Associated Peripheral Nervous System Disorders.

Authors:  Madalina Huruba; Andreea Farcas; Daniel Corneliu Leucuta; Camelia Bucsa; Cristina Mogosan
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-26

4.  Development of a drug risk analysis and assessment system and its application in signal excavation and analysis of 263 cases of fluoroquinolone-induced adverse reactions.

Authors:  Yuyao Guan; Lei Ji; Lei Zheng; Jing Yang; Yizhuo Qin; Ning Ding; Ting Miao; Xuemei Liu
Journal:  Front Pharmacol       Date:  2022-10-04       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.